Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker KNSA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Michael R. Megna CHIEF ACCOUNTING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 11,280 | $98.54 | $1.1M Sale | Form 4 ↗ |
| Nov 4, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 26,918 | $96.05 | $2.6M Sale | Form 4 ↗ |
| Nov 4, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 29,845 | $95.48 | $2.8M Sale | Form 4 ↗ |
| Nov 4, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 81,742 | $94.20 | $7.7M Sale | Form 4 ↗ |
| Nov 4, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 11,335 | $93.54 | $1.1M Sale | Form 4 ↗ |
| Nov 4, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,460 | $92.35 | $134.8K Sale | Form 4 ↗ |
| Nov 3, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 4,584 | $94.25 | $432.0K Sale | Form 4 ↗ |
| Nov 3, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 145,708 | $93.53 | $13.6M Sale | Form 4 ↗ |
| Nov 3, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 68,664 | $92.70 | $6.4M Sale | Form 4 ↗ |
| Nov 3, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,214 | $90.77 | $110.2K Sale | Form 4 ↗ |
| Nov 2, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 722 | $94.05 | $67.9K Sale | Form 4 ↗ |
| Nov 2, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 11,642 | $93.15 | $1.1M Sale | Form 4 ↗ |
| Nov 2, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 8,932 | $92.05 | $822.2K Sale | Form 4 ↗ |
| Nov 2, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 6,681 | $91.23 | $609.5K Sale | Form 4 ↗ |
| Nov 2, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 220 | $94.01 | $20.7K Sale | Form 4 ↗ |
| Nov 2, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 12,034 | $93.13 | $1.1M Sale | Form 4 ↗ |
| Nov 2, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 10,502 | $92.03 | $966.5K Sale | Form 4 ↗ |
| Nov 2, 2026 | Mark Ragosa CHIEF FINANCIAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 14,027 | $91.40 | $1.3M Sale | Form 4 ↗ |
| Nov 2, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 704 | $94.09 | $66.2K Sale | Form 4 ↗ |
| Nov 2, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 16,810 | $93.42 | $1.6M Sale | Form 4 ↗ |
| Nov 2, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 899 | $92.37 | $83.0K Sale | Form 4 ↗ |
| Nov 2, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 100 | $93.97 | $9,397 Sale | Form 4 ↗ |
| Nov 2, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 26,781 | $93.06 | $2.5M Sale | Form 4 ↗ |
| Nov 2, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 24,188 | $91.83 | $2.2M Sale | Form 4 ↗ |
| Nov 2, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 38,364 | $91.03 | $3.5M Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 2,575 | $97.76 | $251.7K Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,760 | $97.10 | $170.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 3,672 | $96.03 | $352.6K Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 6,282 | $94.92 | $596.3K Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 8,430 | $93.97 | $792.2K Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 15,114 | $92.81 | $1.4M Sale | Form 4 ↗ |
| Oct 30, 2026 | Ross Moat CHIEF OPERATING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 37,775 | $92.00 | $3.5M Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 2,155 | $97.77 | $210.7K Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,925 | $97.06 | $186.8K Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 4,000 | $95.97 | $383.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 4,821 | $94.86 | $457.3K Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 6,841 | $93.91 | $642.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 16,056 | $92.85 | $1.5M Sale | Form 4 ↗ |
| Oct 30, 2026 | John F. Paolini CHIEF MEDICAL OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 41,789 | $92.02 | $3.8M Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,440 | $98.16 | $141.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 2,316 | $97.34 | $225.4K Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 4,490 | $95.97 | $430.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 8,888 | $94.72 | $841.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 15,903 | $93.62 | $1.5M Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 18,685 | $92.77 | $1.7M Sale | Form 4 ↗ |
| Oct 30, 2026 | Sanj K. Patel CHAIRMAN & CEO, Director | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 41,169 | $92.01 | $3.8M Sale | Form 4 ↗ |
| Oct 30, 2026 | Michael R. Megna CHIEF ACCOUNTING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 5,350 | $97.74 | $522.9K Sale | Form 4 ↗ |
| Oct 30, 2026 | Michael R. Megna CHIEF ACCOUNTING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 1,691 | $97.11 | $164.2K Sale | Form 4 ↗ |
| Oct 30, 2026 | Michael R. Megna CHIEF ACCOUNTING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 3,145 | $96.08 | $302.2K Sale | Form 4 ↗ |
| Oct 30, 2026 | Michael R. Megna CHIEF ACCOUNTING OFFICER | KNSA Kiniksa Pharmaceuticals International, plc | Sale | 3,705 | $94.86 | $351.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:11 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances